TDP-43 (N-terminal) Recombinant monoclonal antibody 80002-1-RR proteintech

$149.00
In stock
SKU
80002-1-RR
Catalog No.SizePrice (USD)
80002-1-RR-20UL20 μL$149.00
80002-1-RR-100UL100 μL$449.00
80002-1-RR-10X100UL1 mL (10 x 100 μL vials)$3,592.00
Catalog Number80002-1-RR
SynonymsTDP-43 (for IF/FC), TARDBP, TDP 43, TDP43, TDP-43
HostRabbit
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA, ChIP-qPCR
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHeLa cells, HAP1 cells, K-562 cells, Neuro-2a cells, C6 cells
Tested Applications — Positive IP detected inHAP1 cells, HeLa cells
Tested Applications — Positive IHC-Autostainer detected inhuman brain tissue
Tested Applications — Positive IHC detected inmouse brain tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF-P detected inrat brain tissue
Tested Applications — Positive IF/ICC detected inHeLa cells, HepG2 cells, SH-SY5Y cells, HAP1 cells
Tested Applications — Positive FC (Intra) detected inHeLa cells
Tested Applications — Positive ChIP-qPCR detected inHEK-293T cells
Recommended Dilutions — Western Blot (WB)WB : 1:20000-1:100000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:1600-1:6400
Recommended Dilutions — Immunofluorescence (IF)-PIF-P : 1:800-1:3200
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Recommended Dilutions — Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
Positive WB detected inHeLa cells, HAP1 cells, K-562 cells, Neuro-2a cells, C6 cells
Positive IP detected inHAP1 cells, HeLa cells
Positive IHC-Autostainer detected inhuman brain tissue
Positive IHC detected inmouse brain tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inrat brain tissue
Positive IF/ICC detected inHeLa cells, HepG2 cells, SH-SY5Y cells, HAP1 cells
Positive FC (Intra) detected inHeLa cells
Positive ChIP-qPCR detected inHEK-293T cells
Western Blot (WB)WB : 1:20000-1:100000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)-AUTOSTAINERIHC-AUTOSTAINER : 1:50-1:500
Immunohistochemistry (IHC)IHC : 1:1600-1:6400
Immunofluorescence (IF)-PIF-P : 1:800-1:3200
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
CHIP-QPCRCHIP-QPCR : 1:10-1:100
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman, mouse
ClassRecombinant
TypeAntibody
ImmunogenCatNo: Ag1231 Product name: Recombinant human TDP-43 protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-260 aa of BC001487 Sequence: MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNA Predict reactive species
Full NameTAR DNA binding protein
Calculated Molecular Weight43 kDa
Observed Molecular Weight43 kDa
GenBank Accession NumberBC001487
Gene SymbolTDP-43
Gene ID (NCBI)23435
RRIDAB_2882934
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDQ13148
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
FC protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IF protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
IP protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
WB protocol for TDP-43 (N-terminal) antibody 80002-1-RRDownload protocol
humanWB,IF Mol Biol Cell Patient-derived induced pluripotent stem cells with a C9orf72 expansion as a model to study frontotemporal dementia pathologies. Authors - Sonia Infante-Tadeo View Article
mouseWB,IF Neural Regen Res 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis Authors - Shi-Shi Jiang View Article
Citations9
DilutionsWB : 1:20000-1:100000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC-AUTOSTAINER : 1:50-1:500 IHC : 1:1600-1:6400 IF-P : 1:800-1:3200 IF/ICC : 1:200-1:800 FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension CHIP-QPCR : 1:10-1:100
IsotypeIgG
ClonalityRecombinant
Clone Number16A22
ConjugationUnconjugated

The TARDBP gene encodes the TDP-43 protein, initially found to repress HIV-1 transcription by binding TAR DNA. TDP-43 has since been shown to bind RNA as well as DNA, and have multiple functions in transcriptional repression, translational regulation and pre-mRNA splicing. For instance, it is reported to regulate alternate splicing of the CTFR gene. In 2006 Neumann et al. found that hyperphosphorylated, ubiquitinated and/or cleaved forms of TDP-43, collectively known as pathological TDP-43, play a major role in the disease mechanisms of ubiquitin-positive, tau- and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in amyotrophic lateral sclerosis (ALS). Proteintech's 80002-1-RR is a rabbit recombinant TDP-43 antibody recognizing N-terminal TDP-43. It recognizes the intact 43 kDa protein as well as all posttranslationally modified and truncated forms in multiple applications. Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659, 19823856, 21666678, 22193176) Recently TDP-43 has been reported to be overexpressed in triple negative breast cancer (TNBC) and it may be a potential target for TNBC diagnosis and drug design. (PMID: 29581274) 80002-1-RR antibody works well in IF experiment. Protocols Product Specific Protocols FC protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IF protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol IP protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol WB protocol for TDP-43 (N-terminal) antibody 80002-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Small-molecule dissolution of stress granules by redox modulation benefits ALS models
    Journal: Nat Chem Biol | Authors: Hiroyuki Uechi | Species: human | Application: IF
  2. 5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
    Journal: Neural Regen Res | Authors: Shi-Shi Jiang | Species: mouse | Application: WB,IF
  3. COVID-19 could worsen cerebral amyloid angiopathy
    Journal: J Neuropathol Exp Neurol | Authors: Julie Dewisme | Species: human | Application: IHC
  4. Patient-derived induced pluripotent stem cells with a C9orf72 expansion as a model to study frontotemporal dementia pathologies.
    Journal: Mol Biol Cell | Authors: Sonia Infante-Tadeo | Species: human | Application: WB,IF
  5. Structural Heterogeneity of TDP-43 Fragments in Alzheimer's Disease and Primary Age-Related Tauopathy by Artificial Intelligence (AI)-Based 3D Segmentation.
    Journal: Neuropathol Appl Neurobiol | Authors: Gokhan Uruk
  6. Elevated TARDBP expression correlates with an unfavorable prognosis, immune evasion, and poor immune efficacy in hepatocellular carcinoma.
    Journal: Transl Cancer Res | Authors: Jungang Tan
  7. Glutaredoxin-1 attenuates transactive response DNA-binding protein 43-induced neurotoxicity by suppressing oxidative stress and transactive response DNA-binding protein 43 aggregation.
    Journal: Neuroreport | Authors: Ji Min Lee | Species: mouse | Application: IF
  8. Patient-derived Induced Pluripotent Stem Cells as a Model to Study Frontotemporal Dementia Pathologies
    Journal: bioRxiv | Authors: Sonia Infante-Tadeo | Species: human | Application: WB
  9. The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence
    Journal: F1000Res | Authors: Donovan Worrall | Species: human | Application: WB,IP,IF

Reviews

Write Your Own Review
You're reviewing:TDP-43 (N-terminal) Recombinant monoclonal antibody 80002-1-RR proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.